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S H O R T  C O M M U N I C A T I O N
INTRODUCTION
Herbal products and dietary supplements are now widely 
available and considered as complementary approaches 
for health promotion. They are intensively used to treat 
and prevent many diseases, such as neurodegenerative 
disorders, dementia, aging, cancer and cardiovascular 
disorders.[1,2] Many people believe in health benefits from 
these herbal preparations which are often linked with 
their antioxidant properties. Various substances, isolated 
from plants, were identified as active molecules in modern 
medicines and many plant extracts work as complex 
mixtures with synergistic effects.
Aquilaria is a genus of  fifteen species of  a tree in the 
Thymelaeaceae, which is native to Southeast Asia. They 
occur particularly in the rain forests of  Thailand, Indonesia, 
Cambodia, Malaysia, Vietnam, Laos, Northern India, 
the Philippines and Borneo. The products of  Aquilaria, 
including agarwood, leaves, etc., have been widely used in the 
treatment of  various kinds of  pain, cough and anaphylaxis 
for hundreds of  years in Asia.[3,4] In general, many Aquilaria 
species, such as Aquilaria sinensis (Lour.) Gilg., Aquilaria 
agallocha Roxb. and Aquilaria crassna, are considered of  
similar medicinal use. Pharmacological studies showed that 
A. agallocha inhibited histamine release from mast cells and 
suppressed the immediate hypersensitivity reaction. [5] It 
may be potentially an anti-inflammatory and/or analgesic 
agent.[6,7] The leaves of  A. sinensis were previously reported 
to have analgesic and anti-inflammatory activities.[8] Leaves 
of  A. sinensis also contained eight α-glucosidase inhibitors,[9] 
which might be used as traditional medicine for the treatment 
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In Thailand, the leaves of Aquilaria crassna have been used traditionally for the treatments of various disorders, but 
without any scientific analysis. In this study, the antipyretic, analgesic, anti‑inflammatory and anti‑oxidative properties 
of A. crassna leaves extract were investigated at a wide dose range in rodents. Experimental animals were treated orally 
with an aqueous extract of Aquilaria crassna leaves (ACE). They were tested for antipyretic (Baker’s yeast-induced fever 
in rats), analgesic (hot plate test in mice) and anti‑inflammatory (carrageenan‑induced paw edema in rats) activities. An 
anti-oxidative effect of ACE was evaluated by using the DPPH anti-oxidant assay. The results showed that, after 5 hours of 
yeast injection, 400 and 800 mg/kg ACE significantly reduced the rectal temperature of rats. Mice were found significantly 
less sensitive to heat at an oral dose of 800 mg/kg ACE, after 60 and 90 min. No anti‑inflammatory activity of ACE at 
an 800 mg/kg dose could be observed in the rat paw assay. An anti-oxidative activity of ACE was observed with an IC50 
value of 47.18 μg/ ml. No behavioral or movement change could be observed in mice after oral administration of ACE (800 
or 8,000 mg/kg) for seven consecutive days. Interestingly, from the second day of treatment, animals had a significant 
lower body weight at the 8,000 mg/kg dose of ACE compared to the control. No toxicity was identified and the results of 
this study state clearly that Aquilaria crassna leaves extracts possess antipyretic, analgesic and anti-oxidative properties 
without anti‑inflammatory activity.
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of  diabetes. Interestingly, many chemical ingredients with 
a similar structure have been isolated from both A. sinensis 
and A. agallocha.[10-12]
In Thailand, the leaves of  A. crassna have been used 
traditionally for the treatments of  various disorders 
and  most recently they have been used as a healthy tea 
food additive. Although the effect of  A. crassna on the 
lipopolysaccharide (LPS)-induced tumor necrosis factor-
alpha (TNF-α) production by human polymorphonuclear 
cells (hPBMC) and cell signaling response has been shown 
recently,[13] no other scientific study has been done to 
elucidate the pharmacological properties of  the active 
ingredients of  A. crassna in order to prove the claims.
MATERIALS AND METHODS
Plant material and extraction
Dried A. crassna leaves (the plant’s voucher No. NAT001-
002, Faculty of  Pharmaceutical Sciences, Khon Kaen 
University) were powdered and macerated with methanol 
for 24 h. The filtrate was dried using a rotary vacuum 
evaporator giving the desired extract in 7.95% yield based 
on the dried leaves. The A. crassna leaves extract (ACE) 
was dissolved fresh in water, everytime before use.
Animals
Male ICR mice weighing 25-35 g, and male Sprague Dawley 
rats weighing 200-300 g were received from the Animal’s 
House, Khon Kaen University, Khon Kaen, Thailand. 
They were maintained under standard environmental 
conditions and were fed with a standard pellet diet and 
water ad libitum.
Antipyretic activity
Baker’s yeast-induced fever
Antipyretic activity tests were performed as described.[14] 
Rats were divided into five groups of  six rats, and they 
were trained to remain quiet in a restraint cage. The rectal 
temperature (TR) was recorded with 0.1°C precision 
by inserting a lubricated digital thermometer (external 
diameter 3 mm) into the rectum of  each animal. After 
measuring basal TR, fever was induced by a subcutaneous 
injection of  a pyrogenic dose of  Baker’s yeast (135 mg/
kg), and subsequently TR was recorded every hour. Two 
hours after injection of  yeast, either water (as the control), 
ACE (200, 400 or 800 mg/kg) or 150 mg/kg aspirin was 
administered orally to each rat, and the TR was recorded 
every hour for another 4 hours. Results are expressed as 
the changes of  the TR from basal TR. From our study, the 
effect of  ACE was clearly seen at 800 mg/kg. Therefore, 
the 800 mg/kg dose was used to study analgesic and anti-
inflammatory activities.
Analgesic activity
Hot plate test
Mice, six in each group, were tested for the reaction time 
by placing them on a hot plate that was thermostatically 
maintained at 50oC with a four-wall plexiglass container, 
confining the animals on the hot plate.[14] Time that each 
mouse spent on the hot plate (until it licked or jumped in 
response to pain) was recorded as the reaction time. The 
cut-off  time of  the test was set at 30 seconds in order to 
prevent tissue damage. The reaction time of  each animal 
was recorded as the basal reaction time. After being orally 
fed with either water, ACE (800 mg/kg) or aspirin (150 mg/
kg), the reaction time of  each animal was determined at 
30, 60 and 90 min after treatment.
Anti-inflammatory activity
Carrageenan-induced paw edema in rats
Rats were divided into three experimental groups (n = 6). 
Different groups were orally treated with water (as the 
control), ACE (800 mg/kg) or aspirin (300 mg/kg). One 
hour after treatment, acute inflammation was produced by 
the sub plantar injection with 0.1 ml of  1% carrageenan in 
the right paw of  the rats.[14] Rat’s paw volume was measured 
at 0, 1, 2 and 3 hours after carrageenan injection using a 
plethysmometer. The results were expressed as the changes 
of  paw volume from the basal value.
Anti-oxidative activity
DPPH antioxidant assay
Anti-oxidative activity of  ACE was determined by DPPH 
(1,1-diphenyl-2-picrylhydrazyl) antioxidant assay as 
described earlier.[15] In brief, the extract was dissolved in 
methanol into various concentrations, including 500, 250, 
125, 63, 31, 16, and 8 g/ml. Ascorbic acid in methanol 
at 5, 2.5, 1.25, 0.63, 0.31, 0.16, and 0.08 g/ml were used 
as reference standard. After adding 0.1 mm DPPH, the 
mixture was incubated in the dark for 30 min and the 
absorbance was measured at 490 nm. Concentration and 
% inhibition of  the oxidation reaction of  ascorbic acid and 
ACE was plotted and the 50% inhibition concentrations 
were determined as IC50.
Effects of repeated doses of ACE, initial toxicity
Water (as the control) or ACE at the doses of  800 mg/kg 
or 8,000 mg/kg (10 times higher than the effective dose) 
was administered orally to mice, once daily for seven days. 
There were 10 mice in each group. Animal behavioral 
changes were observed immediately after treatment up 
to 6 hours. Body weight of  each animal and numbers of  
dead animals (if  any) were recorded daily. At the end of  
the experiment, certain organs (heart, kidney, liver and 
stomach) were isolated, weighed and observed for any 
gross abnormality changes.
Sattayasai, et al.: The effects of Aquilaria crassna leaves extract
Journal of Ayurveda & Integrative Medicine | October-December 2012 | Vol 3 | Issue 4 177
Statistical analysis
Results were expressed as the mean ± S.E.M. Data were 
assessed by one-way analysis of  variance (ANOVA) and 
all pairwise multiple comparison procedures (Fisher LSD 
method). P value of  <0.05 was considered as statistically 
significant.
RESULTS
Antipyretic activity
The results of  the antipyretic activity (Baker’s yeast-induced 
fever) are outlined in Figure 1. Animals that received 
Baker’s yeast (135 mg/kg) had a significant increase in 
the rectal temperature 3 hours after the yeast injection, 
and the increase in TR was continued until the end of  the 
experiment. The animals treated with 200 mg/kg ACE 
showed no antipyretic effect and the animal’s TR during 
the observation period was comparable to the control. 
Animals treated with either 150 mg/kg aspirin or 400 or 
800 mg/kg ACE showed a significant reduction of  TR at 
5 and 6 hours after the yeast injection when compared to 
the control at the same time point.
Hot plate reaction time in mice
The results showed that aspirin 150 mg/kg and ACE 
800 mg/kg could significantly increase the thermal 
threshold when compared to the control [Figure 2]. The 
analgesic effect of  150 mg/kg aspirin could be seen at 
30, 60 and 90 min after oral administration. The effect of  
800 mg/kg ACE was clearly seen at 60 and 90 min after 
oral administration of  the test extract. The magnitude 
of  the effect of  800 mg/kg ACE was significantly 
less than 150 mg/kg aspirin at 60 min and identical at 
90 min.
Anti-inflammatory studies
Following carrageenan injection, the paw edema formation 
was gradually increased within the 1st hour for the control 
group, and the maximum effect was reached over the period 
of  3 hours [Figure 3]. Animals treated with 300 mg/kg 
aspirin showed fewer swollen paws, and the paw volumes 
were significantly less than the control group after 2 and 
3 hours. No anti-inflammatory effect of  800 mg/kg ACE 
could be observed.
Anti-oxidative activity
DPPH antioxidant assay
As shown in Figure 4, ascorbic acid, 0.08-5 g/ml, inhibited 
DPPH oxidation by approximately 30-80%. From 8 to 
500 g/ml ACE, the inhibition was determined in the range 
from 36% to 91%. The anti-oxidative activities of  ascorbic 
acid and ACE were found to have IC50 equal to 2.19 g/ml 
and 47.18 g/ml, respectively.
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Figure 1: Effects of ACE (200, 400 or 800 mg/kg) or 150 mg/kg aspirin 
on rectal temperature of rats. * and # denoted P<0.05 when compared 
to the control at the same time point and basal TR, respectively
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Figure 2: Analgesic effect of ACE. Mice were fed with water (control), 
800 mg/kg ACE or 150 mg/kg aspirin. * and # denoted P<0.05 when 
compared to the control and aspirin-treated group at the same time 
point, respectively
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Figure 3: Carrageenan-induced paw edema test. Rats were fed with 
water (control), 800 mg/kg ACE or 300 mg/kg aspirin. *P<0.05 when 
compared to the control at the same time point
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preferentially within the central nervous system through 
inhibition of  a specific form of  cyclooxygenase.[16] It might 
be possible that ACE, at the dose tested, acts in a similar 
pattern as paracetamol on the COX3 target, but not as 
aspirin or other NSAIDs, by centrally producing those 
effects. However, a higher dose of  ACE might be able to 
show anti-inflammatory activity, since the ethanolic extract 
of  A. sinensis displayed analgesic and anti-inflammatory at 
the dose of  848 but not 424 mg/kg,[8] and the heartwood 
of  A. crassna inhibited LPS-induced tumor necrosis factor-
alpha production by attenuating P38 MAPK activation.
The anti-oxidative activity of  ACE possibly is one of  
the important properties, and although the extract was 
found less active than ascorbic acid, this activity may be 
linked with the phenolic part of  the mixture of  ACE. 
Oxidative mechanisms are proposed to be responsible 
for many neuronal disorders[2,17] and plant compounds are 
suggested to be neuroprotectants due to their anti-oxidative 
properties.[17] Many substances have been identified from 
fresh stem of  A. sinensis such as aquilarin A, balanophonin 
and (+)-lariciresinol[18] and this part of  the mixture might 
also be present in ACE and act as an antioxidant.
In this study, animals treated with the extract of  A. crassna, 
8,000 mg/kg, had a significant reduction of  body weight. 
Recently, the laxative effect of  A. sinensis has been 
reported and explained via acetylcholine receptor mediated 
acceleration of  the gastrointestinal transit.[19,20] Laxative 
effect of  A. sinensis was even observed in rats with low-fiber 
diet-induced constipation without causing any diarrhea 
and the authors suggested that A. sinensis may be useful 
as a therapeutic laxative agent in humans. In addition, 
α-glucosidase inhibitors were reported to be present in 
A. sinensis leaves which might interfere the absorption of  
carbohydrate food.[20,11] It might be the case that A. crassna 
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Figure 4: Comparison of DPPH radical scavenging capacity (%) of 
ascorbic acid and ACE
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Figure 5: ACE treatment and animal’s body weight. Mice were fed 
once daily with water (control) or ACE. *P<0.05 when compared to 
the control at the same time point
Effects of repeated doses of ACE
In general, animals treated with ACE at either 800 or 
8,000 mg/kg showed no abnormal behavior. Interestingly, 
the repeated oral administration of  8,000 mg/kg ACE 
once daily for seven days, showed a significant reduction 
of  the animal’s body weight from day 2 until the end of  the 
experiment when compared to the control [Figure 5]. No 
effect could be observed on weights or gross appearances 
of  the heart, liver, kidney and stomach in animals treated 
with ACE at either 800 or 8,000 mg/kg for seven days 
(data not shown).
DISCUSSION
In this study, it was clearly shown that the methanolic 
extract of  A. crassna leaves (ACE) possesses antipyretic 
(Baker’s yeast-induced fever in rats), analgesic (hot plate 
test in mice) and anti-oxidative (DPPH antioxidant assay) 
activities without anti-inflammatory activity (carrageenan-
induced paw edema in rat). No effects on general behaviors 
of  mice could be observed after repeated dose’s treatment 
(seven consecutive days) of  ACE, at either 800 mg/kg 
or 8,000 mg/kg. Most interestingly, from the second day 
of  treatment, animals that received 8000mg/kg of  ACE, 
displayed a significant lower body weight than the control.
Aspirin, an analgesic antipyretic and anti-inflammatory 
drug, was used as a positive control in this study. The 
mechanisms of  actions of  aspirin that are responsible 
for all those effects are believed to be involved with both 
central and peripheral mechanisms.[16] In this study, ACE, 
at 800 mg/kg, showed an antipyretic and analgesic effect, 
which is comparable to aspirin at 150 mg/kg, but without 
anti-inflammatory properties. A comparable drug, such as 
paracetamol, also displays analgesic and antipyretic effects 
without anti-inflammatory action, and it is proposed to act 
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leaves extract exerts its effect on body weight through 
both mechanisms and these need to be further elucidated.
In conclusion, this study suggests the possibility of  
using A. crassna leaves and a formulation thereof  as an 
analgesic and antipyretic food supplement. Further, a 
medicinal application of  the antioxidant and the possible 
α-glucosidase inhibiting property of  the extract might have 
some roles in the treatment and prevention of  metabolic 
disorders.
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